Since VEGF inhibitors, especially when combined with immunotherapy, demonstrated well the clinical efficacy in several caners including HCC (37–39), we compared the VEGF signaling network between P-ICC and T-ICC ecosystems (Figures 2F, G). Here, VEGFA is linked to intrahepatic cholangiocarcinoma.